Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: A comprehensive guide to their chemical structure diversity in drug development

Zhong Chuanxin, Wang Shengzheng, Dang Lei, Xie Duoli, Liu Jin, Ren Fuzeng, Aiping LYU, Ge Zhang*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: A comprehensive guide to their chemical structure diversity in drug development'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds